Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bayer
Bayer
European regulator endorses high-dose version of Bayer eye drug Eylea
Reuters
Fri, 11/10/23 - 10:09 am
Bayer
EMA
Eylea
Roche
Bayer CEO Anderson says 'radical realignment' is underway
Fierce Pharma
Wed, 11/8/23 - 12:05 pm
Bayer
Pharma CEOs
Bill Anderson
layoffs
Bayer adds a new life science incubator in China
Pharmaphorum
Tue, 11/7/23 - 10:04 am
Bayer
Co.Lab
incubators
China
oncology
cell therapy
gene therapy
Bayer doubles down on Factor XIa with new phase 3 trial
Pharmaphorum
Mon, 11/6/23 - 09:56 am
Bayer
clinical trials
asundexian
Factor Xa inhibition
atrial fibrillation
Novo Nordisk, with coffers filling with cash, buys rival to Bayer's kidney drug Kerendia in $1.3B deal
Fierce Biotech
Mon, 10/16/23 - 10:24 am
Novo Nordisk
KBP Biosciences
Bayer
chronic kidney disease
Kerendia
ocedurenone
hypertension
Bayer christens $250M cell therapy 'launch facility' in Berkeley
Fierce Pharma
Tue, 10/10/23 - 11:55 am
Bayer
cell therapy
Berkeley
Californi
BlueRock Therapeutics
Bayer CEO plots management cuts as first step in larger overhaul
Fierce Pharma
Fri, 09/15/23 - 11:53 am
Bayer
Pharma CEOs
Bill Anderson
layoffs
Bayer Is Rapidly Expanding Its Footprint With Artificial Intelligence
ForbesBayer Is Rapidly Expanding Its Footprint With Artificial Intelligence
Tue, 09/5/23 - 11:21 am
Bayer
artificial intelligence
Google
Bayer looks to expand Kerendia label to include heart failure
Clinical Trials Arena
Fri, 09/1/23 - 12:38 pm
Bayer
Kerendia
clinical trials
heart failure
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
MedCity News
Mon, 08/28/23 - 08:21 pm
Bayer
cell therapy
Parkinson's Disease
clinical trials
Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study
Fierce Biotech
Mon, 08/28/23 - 11:37 am
Bayer
Parkinson's Disease
cell therapy
bemdaneprocel
BlueRock Therapeutics
Bayer's digital drive in consumer health gathers pace
Pharmaphorum
Wed, 08/23/23 - 10:08 am
Bayer
consumer health
digital health
Mahana Therapeutics
Bayer pledges $500K in drugs and cash relief to Maui following devastating wildfires
Fierce Pharma
Thu, 08/17/23 - 11:35 pm
Bayer
Hawaii
Maui
wildfires
donations
Bayer-bought BlueRock cuts 12% of workforce across 3 sites as pipeline contracts
Fierce Biotech
Thu, 08/17/23 - 11:32 pm
BlueRock Therapeutics
Parkinson's Disease
Bayer
layoffs
With sales in free fall, Bayer's new CEO Anderson considers structural change
Fierce Pharma
Tue, 08/8/23 - 10:34 pm
Bayer
Pharma CEOs
Bill Anderson
Bayer ends respiratory distress drug development in latest phase 2 cleanout
Fierce Pharma
Tue, 08/8/23 - 10:21 am
Bayer
adrenomedullin pegol
earnings
ARDS
Bayer expects gloomier 2023 as lower glyphosate sales bolster breakup advocates' case
Fierce Pharma
Tue, 07/25/23 - 11:56 am
Bayer
earnings
Check out the most-seen pharma brand TV debuts of 2023
Medical Marketing and Media
Wed, 07/19/23 - 05:49 pm
TV ads
DTC advertising
Bayer
AbbVie
Bristol Myers Squibb
Bayer's Parkinson's cell therapy passes early clinical safety test, clearing path to phase 2
Fierce Biotech
Wed, 06/28/23 - 10:05 am
Bayer
Parkinson's Disease
clinical trials
cell therapy
bemdaneprocel
Bayer needs 'midsize acquisition' to reach $10B oncology sales goal, exec says
Fierce Pharma
Mon, 06/12/23 - 11:22 pm
Bayer
oncology
M&A
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »